Ligand Pharmaceuticals (LGND) EBT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142.72% |
| Dec 31, 2025 | -59.77% |
| Sep 30, 2025 | 1,157.57% |
| Jun 30, 2025 | 122.37% |
| Mar 31, 2025 | -28.01% |
| Dec 31, 2024 | -518.39% |
| Sep 30, 2024 | 90.31% |
| Jun 30, 2024 | -157.64% |
| Mar 31, 2024 | 563.55% |
| Dec 31, 2023 | 240.79% |
| Sep 30, 2023 | -482.97% |
| Jun 30, 2023 | -94.29% |
| Mar 31, 2023 | 130.06% |
| Dec 31, 2022 | 95.40% |
| Sep 30, 2022 | 42.64% |
| Jun 30, 2022 | 194.72% |
| Mar 31, 2022 | -151.14% |
| Dec 31, 2021 | 17.18% |
| Sep 30, 2021 | -54.18% |
| Jun 30, 2021 | 477.74% |
| Mar 31, 2021 | -62.08% |
| Dec 31, 2020 | 230.90% |
| Sep 30, 2020 | -141.30% |
| Jun 30, 2020 | 192.45% |
| Mar 31, 2020 | -272.05% |
| Dec 31, 2019 | 58.86% |
| Sep 30, 2019 | -10.22% |
| Jun 30, 2019 | -102.14% |
| Mar 31, 2019 | 1,583.94% |
| Dec 31, 2018 | -171.68% |
| Sep 30, 2018 | -17.11% |
| Jun 30, 2018 | 72.80% |
| Mar 31, 2018 | 80.38% |
| Dec 31, 2017 | 154.04% |
| Sep 30, 2017 | 45.43% |
| Jun 30, 2017 | 34.02% |
| Mar 31, 2017 | -14.33% |
| Dec 31, 2016 | 496.94% |
| Sep 30, 2016 | 112.05% |
| Jun 30, 2016 | -205.02% |
| Mar 31, 2016 | 64.22% |
| Dec 31, 2015 | -19.99% |
| Sep 30, 2015 | -67.32% |
| Jun 30, 2015 | 30,224.32% |
| Mar 31, 2015 | -101.06% |
| Dec 31, 2014 | 678.14% |
| Sep 30, 2014 | -27.40% |
| Jun 30, 2014 | -42.28% |
| Mar 31, 2014 | 7.18% |
| Dec 31, 2013 | -0.94% |
| Sep 30, 2013 | -46.77% |
| Jun 30, 2013 | 177.66% |
| Mar 31, 2013 | 44.21% |
| Dec 31, 2012 | 1,926.92% |
| Sep 30, 2012 | 98.70% |
| Jun 30, 2012 | -416.17% |
| Mar 31, 2012 | -115.50% |
| Dec 31, 2011 | 220.02% |
| Sep 30, 2011 | -437.65% |
| Jun 30, 2011 | 81.19% |
| Mar 31, 2011 | -158.92% |
| Dec 31, 2010 | 86.12% |
| Sep 30, 2010 | -3,513.73% |